Codner Iris Beck 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Feb 12, 2018

Insider Transaction Report

Form 4
Period: 2018-02-09
Codner Iris Beck
EVP Global Brand&Communication
Transactions
  • Award

    Stock Options (right to buy)

    2018-02-09+86,76286,762 total
    Exercise: $18.61Exp: 2028-02-08Ordinary Shares (86,762 underlying)
  • Award

    Restricted Share Units

    2018-02-09+34,03134,031 total
    Ordinary Shares (34,031 underlying)
Footnotes (4)
  • [F1]Stock options were granted on February 9, 2018, with 28,920 vesting on each of February 9, 2020 and February 9, 2021 and 28,922 vesting on February 9, 2022.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F3]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F4]Restricted share units were granted on February 9, 2018, with 11,343 vesting on each of February 9, 2020 and February 9, 2021 and 11,345 vesting on February 9, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION